1. Bonita R: Stroke prevention: global perspective. In Stroke Prevention. Edited by: Norris JW, Hachinksi V. New York: Oxford University Press; 2001:259–274.
2. Sacco RL, Wolf PA, Gorelick PB: Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology 1999, 53: S15-S24.
3. Kaste M, Fogelholm R, Rissanen A: Economic burden of stroke and the evaluation of new therapies. Public Health 1998, 112: 103–112.
4. Sacco RL, Boden-Albala B: Stroke risk factors: identification and modification. In Stroke Therapy. 2nd edition. Edited by: Fisher M. Woburn, MA: Butterworth-Heinemann; 2001:1–24.
5. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992, 32: 78–86. 10.1002/ana.410320113